| Literature DB >> 27035566 |
Jiangtao Zhao1, Liguo Jian1, Lihua Zhang1, Tongbin Ding1, Xiaowei Li1, Dong Cheng1, Shaohui Niu1, Liqiang Sun1, En Li1, Shichao Liu1, Youxu Jiang1, Lu Liu2.
Abstract
Vascular smooth muscle cell (VSMC) proliferation and migration are critical in the progression of atherosclerosis and can be induced by platelet-derived growth factor (PDGF). Several studies have demonstrated that scavenger receptor class A, member 5 (SCARA5) is important in cancer cell migration and invasion. However, the role of SCARA5 in VSMCs remains to be elucidated in the development of atherosclerosis. Therefore, the role of SCARA5 was investigated in PDGF‑BB‑stimulated VSMC proliferation and migration. In the present study, it was shown that SCARA5 expression was enhanced by PDGF‑BB in human aortic smooth muscle cells (HASMCs). Knockdown of SCARA5 by small interfering (si)RNA significantly inhibited PDGF‑BB‑induced HASMC proliferation and migration. Furthermore, siRNA‑SCARA5 significantly inhibited the phosphorylation of PDGF receptor (PDGFR) β, AKT and extracellular signal‑regulated kinase 1/2 in PDGF‑BB‑stimulated HASMCs. In conclusion, this study demonstrated that knockdown of SCARA5 inhibits PDGF‑BB‑induced HASMC proliferation and migration through suppression of the PDGF signaling pathway. Thus, SCARA5 may be a novel therapeutic target for preventing or treating vascular diseases involving VSMC proliferation and migration.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27035566 DOI: 10.3892/mmr.2016.5074
Source DB: PubMed Journal: Mol Med Rep ISSN: 1791-2997 Impact factor: 2.952